Network Immunology Announces Data for Entirely Novel Method of HIV Therapy: TheraNet™

Released

Atlanta, GA: Network Immunology reports highly encouraging results have been observed with respect to its HIV therapeutic technology, TheraNet™. In the company’s first study involving TheraNet™ caused an average 86% reduction in viral load in two of four SIV infected macaque monkeys.  TheraNet™ is an entirely new method of HIV therapy, based on the immune network framework. "This therapeutic is entirely different from the existing mainstream anti-retroviral drugs which cause very substantial side-effects.  And, because it works with the system, we expect very minimal, and even potentially no side-effects", says George Hoffmann, President and CEO.

Corporate Updates

Captcha Image